LUXHT
Index Performance
Overview
Description
The coming years will welcome a new breed of historically important, publicly listed healthcare technology companies that more closely resemble the tech mega-caps of today, with platform-based innovation, highly scalable business models, network effects, high impact, and high value creation. Technologies such as teleoperated devices, wearable sensors, and machine learning and artificial intelligence are arming patients and healthcare providers with tools to make better and quicker clinical decisions. The intersection of healthcare and technology has the potential to transform everything from how patients interact with care providers, to how diagnostic data is obtained and analyzed, from the ways interventions are recommended to the ways outcomes are measured. Developed by Lux Capital, the Lux Health + Tech Index™ recognizes the life-changing power of healthcare + technology.
Full methodology- TickerLUXHT
- Inception Date04/27/2021
- WeightingCustom
- # of holdings44
What's inside?
Holdings
All holdings as of April 22, 2024
| Oscar Health, Inc. (OSCR) | 12.72% | $3.14B | 47.92% | N/A | 0.40 |
| Natera, Inc. (NTRA) | 5.58% | $10.70B | 31.99% | 45.52% | 6.25 |
| Align Technology, Inc. (ALGN) | 4.17% | $22.65B | 3.42% | 70.39% | 5.21 |
| GoodRx Holdings, Inc. (GDRX) | 3.84% | $621.15M | -2.12% | 77.33% | 3.72 |
| EXACT Sciences Corp. (EXAS) | 3.50% | $11.33B | 19.93% | 70.14% | 6.05 |
| Hims & Hers Health, Inc. (HIMS) | 3.33% | $2.45B | 65.49% | 80.90% | 1.89 |
| Accolade, Inc. (ACCD) | 3.13% | $712.92M | 9.26% | 33.63% | 1.74 |
| Lifestance Health Group, Inc. (LFST) | 2.94% | $2.23B | 22.82% | 21.00% | 3.13 |
| Inspire Medical Systems, Inc. (INSP) | 2.90% | $6.82B | 53.19% | 84.54% | 8.84 |
| Axonics, Inc. (AXNX) | 2.75% | $3.41B | 33.86% | 72.46% | 7.47 |
| iRhythm Technologies, Inc. (IRTC) | 2.73% | $3.52B | 19.90% | 67.35% | 6.62 |
| Intuitive Surgical, Inc. (ISRG) | 2.72% | $130.86B | 11.46% | 65.87% | 19.01 |
| Veeva Systems, Inc. (VEEV) | 2.64% | $32.12B | 9.68% | 70.73% | 12.67 |
| NeoGenomics, Inc. (NEO) | 2.62% | $1.71B | 16.07% | 35.40% | 3.76 |
| Schrödinger, Inc. (SDGR) | 2.61% | $1.55B | 19.73% | 64.66% | 10.82 |
| Hologic, Inc. (HOLX) | 2.60% | $17.89B | -5.69% | 54.70% | 4.49 |
| DexCom, Inc. (DXCM) | 2.58% | $50.70B | 24.49% | 62.97% | 14.54 |
| IQVIA Holdings, Inc. (IQV) | 2.48% | $42.11B | 3.77% | 27.35% | 3.73 |
| Progyny, Inc. (PGNY) | 2.28% | $3.19B | 38.34% | 21.94% | 3.12 |
| Myriad Genetics, Inc. (MYGN) | 2.19% | $1.66B | 11.03% | 62.96% | 2.12 |
| Definitive Healthcare Corp. (DH) | 1.95% | $863.39M | 12.92% | 65.60% | 5.64 |
| Fulgent Genetics, Inc. (FLGT) | 1.84% | $612.37M | -53.27% | 33.40% | 1.55 |
| Veracyte, Inc. (VCYT) | 1.73% | $1.49B | 21.76% | 61.81% | 4.97 |
| Teladoc Health, Inc. (TDOC) | 1.58% | $2.25B | 8.13% | 57.84% | 1.54 |
| Guardant Health, Inc. (GH) | 1.56% | $2.14B | 25.45% | 59.74% | 5.70 |
| Health Catalyst, Inc. (HCAT) | 1.56% | $325.61M | 7.13% | 31.29% | 1.53 |
| Clover Health Investments Corp. (CLOV) | 1.53% | $252.39M | -41.81% | N/A | 0.23 |
| PROCEPT BioRobotics Corp. (PRCT) | 1.47% | $2.61B | 81.55% | 52.17% | 13.23 |
| Masimo Corp. (MASI) | 1.41% | $7.11B | 0.60% | 49.00% | 3.49 |
| Tandem Diabetes Care, Inc. (TNDM) | 1.36% | $2.05B | -6.68% | 47.33% | 2.50 |
| ResMed, Inc. (RMD) | 1.29% | $26.53B | 12.48% | 54.64% | 5.90 |
| 10X Genomics, Inc. (TXG) | 1.25% | $2.94B | 19.81% | 66.15% | 10.12 |
| Globus Medical, Inc. (GMED) | 1.22% | $5.79B | 53.34% | 61.80% | 3.90 |
| Castle Biosciences, Inc. (CSTL) | 1.18% | $538.29M | 60.38% | 74.72% | 1.60 |
| Illumina, Inc. (ILMN) | 1.13% | $19.11B | -1.75% | 61.06% | 5.15 |
| Doximity, Inc. (DOCS) | 1.11% | $3.03B | 17.37% | 90.99% | 10.52 |
| Twist Bioscience Corp. (TWST) | 1.03% | $1.70B | 31.81% | 40.51% | 7.24 |
| Olink Holding AB (OLK) | 1.03% | $2.74B | 21.60% | 58.19% | 17.80 |
| CareDx, Inc. (CDNA) | 1.00% | $423.03M | -12.89% | 62.74% | 1.58 |
| Insulet Corp. (PODD) | 0.95% | $11.51B | 30.02% | 68.84% | 9.85 |
| Cytek Biosciences, Inc. (CTKB) | 0.76% | $758.78M | 17.67% | 56.69% | 5.20 |
| Nevro Corp. (NVRO) | 0.68% | $446.60M | 4.63% | 65.51% | 1.58 |
| Adaptive Biotechnologies Corp. (ADPT) | 0.64% | $364.18M | -8.11% | 42.57% | 3.47 |
| Pacific Biosciences of California, Inc. (PACB) | 0.41% | $424.76M | 56.29% | 20.12% | 13.92 |
